Watchlist Price Alert

Fennec Pharmaceuticals In... (FENC)

NASDAQ: FENC · Real-Time Price · USD

8.30

-0.15 (-1.78%)

At close: Jun 25, 2025, 1:10 PM

Fennec Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	47.54M	21.25M	1.53M	n/a	170K	n/a	n/a	n/a	n/a
Cost of Revenue	3.18M	1.26M	86K	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	44.35M	19.99M	1.45M	n/a	170K	n/a	n/a	n/a	n/a
Operating Income	2.57M	-12.77M	-22.59M	-17.22M	-17.89M	-13.01M	-10.41M	-6.95M	-2.87M
Interest Income	1.59M	441K	195K	54K	87K	322.32K	n/a	n/a	n/a
Pretax Income	-71K	-16.05M	-23.71M	-17.35M	-18.11M	-12.78M	-9.89M	-7.05M	-2.79M
Net Income	-436K	-16.05M	-24.84M	-17.46M	-17.92M	-12.46M	-9.89M	-7.05M	-2.79M
Selling & General & Admin	41.48M	32.71M	20.51M	12.24M	12.95M	7.4M	5.4M	5.01M	2.4M
Research & Development	307K	56K	3.53M	4.98M	5.11M	5.61M	5.01M	1.94M	472K
Other Expenses	n/a	n/a	n/a	n/a	-9K	-17K	6K	-8K	-14K
Operating Expenses	41.79M	32.76M	24.04M	17.22M	18.05M	13.01M	10.41M	6.95M	2.87M
Interest Expense	4.07M	3.39M	978K	126K	9K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	18.43M	12.12M	2.79M	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	44.97M	34.02M	24.12M	17.22M	18.05M	13.01M	10.41M	6.95M	2.87M
Income Tax Expense	365K	n/a	1.13M	110K	-187K	-315K	-348K	-47K	-8K
Shares Outstanding (Basic)	27.29M	26.57M	26.27M	26.01M	23.7M	19.9M	18.94M	14.99M	12.68M
Shares Outstanding (Diluted)	27.29M	26.57M	26.27M	26.01M	23.7M	19.9M	19.02M	15.01M	12.77M
EPS (Basic)	-0.02	-0.6	-0.95	-0.67	-0.76	-0.63	-0.52	-0.47	-0.22
EPS (Diluted)	-0.02	-0.6	-0.95	-0.67	-0.76	-0.63	-0.52	-0.47	-0.22
EBITDA	3.6M	-12.36M	-22.59M	-123K	-17.89M	234K	521K	-95K	82K
EBIT	2.57M	-12.65M	-22.74M	-17.07M	-18.1M	-13.07M	-9.38M	-7.3M	-2.76M
Depreciation & Amortization	1.03M	287K	149K	17.22M	402K	13.01M	10.41M	6.95M	2.87M